These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9760695)

  • 1. Orally active growth hormone secretagogues.
    Patchett AA; Smith RG; Wyvratt MJ
    Pharm Biotechnol; 1998; 11():525-54. PubMed ID: 9760695
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
    Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of growth hormone secretagogues.
    Smith RG
    Endocr Rev; 2005 May; 26(3):346-60. PubMed ID: 15814848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic targets for growth hormone secretagogues.
    Robinson IC
    Acta Paediatr Suppl; 1997 Nov; 423():88-91. PubMed ID: 9401551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.
    Holst B; Brandt E; Bach A; Heding A; Schwartz TW
    Mol Endocrinol; 2005 Sep; 19(9):2400-11. PubMed ID: 15905359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent 3-spiropiperidine growth hormone secretagogues.
    Yang L; Morriello G; Prendergast K; Cheng K; Jacks T; Chan WW; Schleim KD; Smith RG; Patchett AA
    Bioorg Med Chem Lett; 1998 Jan; 8(1):107-12. PubMed ID: 9925440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.
    Hansen TK; Ankersen M; Raun K; Hansen BS
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1915-8. PubMed ID: 11459660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues.
    Barakat KJ; Cheng K; Chan WW; Butler BS; Jacks TM; Schleim KD; Hora DF; Hickey GJ; Smith RG; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1431-6. PubMed ID: 9871779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
    Li J; Chen SY; Murphy BJ; Flynn N; Seethala R; Slusarchyk D; Yan M; Sleph P; Zhang H; Humphreys WG; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4072-4. PubMed ID: 18554903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues.
    Chen MH; Pollard PP; Patchett AA; Cheng K; Wei L; Chan WW; Butler B; Jacks TM; Smith RG
    Bioorg Med Chem Lett; 1999 May; 9(9):1261-6. PubMed ID: 10340611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretagogues: mechanism of action and use in aging.
    Fuh VL; Bach MA
    Growth Horm IGF Res; 1998 Feb; 8(1):13-20. PubMed ID: 10990440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).
    Schoen WR; Pisano JM; Prendergast K; Wyvratt MJ; Fisher MH; Cheng K; Chan WW; Butler B; Smith RG; Ball RG
    J Med Chem; 1994 Apr; 37(7):897-906. PubMed ID: 8151616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway.
    Bailey AR; von Engelhardt N; Leng G; Smith RG; Dickson SL
    J Neuroendocrinol; 2000 Mar; 12(3):191-7. PubMed ID: 10718914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonpeptidyl growth hormone secretagogue.
    Smith RG; Cheng K; Schoen WR; Pong SS; Hickey G; Jacks T; Butler B; Chan WW; Chaung LY; Judith F
    Science; 1993 Jun; 260(5114):1640-3. PubMed ID: 8503009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus.
    Bailey AR; Giles M; Brown CH; Bull PM; Macdonald LP; Smith LC; Smith RG; Leng G; Dickson SL
    Neuroendocrinology; 1999 Aug; 70(2):83-92. PubMed ID: 10461022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent GH responses to repeated injection of GH-releasing hexapeptide (GHRP-6) and the non-peptide GH secretagogue, L-692,585.
    Fairhall KM; Mynett A; Smith RG; Robinson IC
    J Endocrinol; 1995 Jun; 145(3):417-26. PubMed ID: 7636426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone secretagogues: discovery of small orally active molecules by peptidomimetic strategies.
    Ankersen M
    Prog Med Chem; 2002; 39():173-214. PubMed ID: 12536673
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone secretagogues as therapeutic agents.
    Svensson J
    Growth Horm IGF Res; 1999 Apr; 9 Suppl A():107-9. PubMed ID: 10429892
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats.
    Lee J; Kwon A; Chae HW; Lee WJ; Kim TH; Kim HS
    Yonsei Med J; 2018 Dec; 59(10):1174-1180. PubMed ID: 30450851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclic structural variants of growth hormone secretagogue L-692,429.
    Lin P; Pisano JM; Schoen WR; Cheng K; Chan WW; Butler BS; Smith RG; Fisher MH; Wyvratt MJ
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3237-42. PubMed ID: 10576695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.